Introduction: Diabetic foot is one of the common complications associated with diabetes. The treatment of metformin may help in reducing the prevalence of diabetic foot ulcer among diabetic patients.
INTRODUCTION:
Diabetes is not a single disease, but it is agroup of metabolic diseases and characterized by hyperglycemia and abnormal lipid metabolism, carbohydrates and insulin resistance and is considered as the main cause of death globally for non-communicable diseases 1 .
Epidemiological studies showed that about 382 million people were diagnosed to have DM in 2013 in global level and this number is expected to increase to 592 million casesworldwide 2 .Diabetes is associated with various complications such as cardiovascular complications, vascular insufficiency, renal damage, retinopathy and diabetic foot (DF). These complications lead to low quality of lifeof diabetic patients 3 and burden healthcare systems [4] [5] [6] [7] .
DF is considered one of the most important complications of diabetics with large cost impacts and quality of life of the patients. DF is the main cause of non-traumatic amputation at global level 4, 8 .At the international level, the prevalence of DF has been estimated to range from 4.4 to 10.5% 9 .
The development of diabetic foot lesions is considered a complicated matter and requires the presence of three factors: neuropathy, peripheral vascular disease, and infection [10] [11] . Several studies have indicated to the mechanisms by which metformin lowers the risks of microvascular and macrovascular disease including reduced weight gain and hyperinsulinemia, enhancing the function of endothelial function, and fibrinolysis, and reduction of lowgrade inflammation, oxidative stress, and glycation [12] [13] [14] .
Patients with diabetes mellitus are more likely to need insulin treatment 15 . However, other studies conducted in diabetic patients treated with insulin have revealed the potential of metformin to enhance glycemic control and to lower insulin needs and weight gain [16] [17] [18] .
STUDY OBJECTIVES:
To investigate the prevalence of diabetic foot ulcer among diabetic patients attending out-clinic patients at Jordanian Royal Medical Services and to investigate the impact of metformin treatment in the development of diabetic foot ulcer.
METHODOLOGY:
A retrospective design was conducted to collect data from files of diabetic patients. Study sample included 62 files of diabetic patients. Study variables included some demographic variables such as gender and age; and clinical variables such as duration of diabetes, treatment with metformin, and the status of diabetic foot ulcer. Data were collected and entered into SPSS version 20 for analyzing purposes. Statistical analysis included descriptive features such as frequency, percentage, mean and standard deviation. The relationship between variables was examined using various statistical models such as Chi-Square test, One Way Anova, and Pearson's correlation. The significance was accepted if p< 0.05.
RESULTS:

Characteristics of study participants
Data presented in table (1) indicated that there were 62 diabetic patients in the study. The mean age was 56.95+11.98 years. The frequency of gender revealed that males were 33 (53.2%) ( Figure 1) ; the duration of diabetes was 7.5+5.86 years; metformin use was documented in about 66% of diabetic patients ( Figure  2) ; the mean of metformin dose was 1617.32+649.49 mg, and the prevalence of DF was 8.1% (figure 3). The relationship between DF and study variables
The relationship between diabetic DF and study variables was investigated based on Chi-Square test.
The relationship between DF and gender was not statistically significant (p=0.658). The relationship between DF and metformin use was also investigated and it was not statistically significant (p=0.157). A trend was observed in which all diabetic patients who developed DF were treated by metformin (table 2) . Correlation between study variables: The correlation between study variables was examined, the only significant correlation was observed between DF and metformin dose (p=0.308). DISCUSSION: The present study was conducted to determine the prevalence of DF among diabetic patients and to investigate the impact of metformin treatment in the development of diabetic foot ulcer.
The results of this study showed that the prevalence of DF was 8.1%. Actually, this finding is consistent with other studies in which the prevalence of DF ranged from 4.4 to 10.5% 9 . Due to the considerations that diabetes has an increasing prevalence over the time, and the impacts of DF from economic and quality of life 4, 8 , it is crucial to control diabetes to minimize these impacts.
The results of this study showed that DF was significantly associated with metformin dose (p=0.05).This finding is consistent with other reported studies in literature. These studies put focus on the mechanisms by which metformin lowers the risks of microvascular and macrovascular disease such as lowering weight gain and hyperinsulinemia, enhancing the function of endothelial function, and fibrinolysis, and reduction of low grade inflammation, oxidative stress, and glycation [12] [13] [14] .
Other studies showed that other benefits of metformin treatment through enhance glycemic control and to lower insulin needs and weight gain [16] [17] [18] .
CONCLUSIONS:
The present study showed that treatment by metformin is associated significantly with metformin dose and could help diabetic patients against developing DF. 
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